Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Optimal Selection of Targeted Therapies for Melanoma Patients: Role of the Mitogen-Activated Protein Kinase Pathway
Introduction Metastatic melanoma is a chemotherapy refractory disease and historical treatment options have been limited. Dacarbazine was once considered the standard systemic treatment despite a response rate of only 5–15% and having never demonstrated an improvement in survival ( ).…